Amylyx Pharmaceuticals Inc (AMLX) — Free Cash Flow Generation Index
Amylyx Pharmaceuticals Inc (AMLX) has a Free Cash Flow Generation Index of 0.97x as of December 2023. Free cash flow of $13.20 Million represents 1% of operating cash flow ($13.55 Million). Explore Amylyx Pharmaceuticals Inc (AMLX) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Amylyx Pharmaceuticals Inc Free Cash Flow Generation Index (2023–2023)
Historical FCF Generation Index trend for Amylyx Pharmaceuticals Inc across 1 annual periods. For the full cash flow conversion analysis, see AMLX operating cash flow.
Annual Free Cash Flow Generation for Amylyx Pharmaceuticals Inc (2023–2023)
Year-by-year Free Cash Flow Generation Index for Amylyx Pharmaceuticals Inc. Check AMLX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.90x | $10.68 Million | $11.92 Million | $1.24 Million | — |